Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation.

[1]  O. Rascol,et al.  Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. , 2002, Archives of neurology.

[2]  D. Geschwind,et al.  Dementia and neurodevelopmental predisposition: Cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia , 2001, Annals of neurology.

[3]  M. Hutton,et al.  Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.

[4]  J. Grafman,et al.  Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation , 2000, Annals of neurology.

[5]  P. Schofield,et al.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene , 2000 .

[6]  S. Reske,et al.  FTDP‐17: An early‐onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation , 1999, Annals of neurology.

[7]  W. Kamphorst,et al.  Phenotypic variation in hereditary frontotemporal dementia with tau mutations , 1999, Annals of neurology.

[8]  Virginia M. Y. Lee,et al.  From genotype to phenotype: A clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP‐17) caused by the P301L tau mutation , 1999, Annals of neurology.

[9]  G. Schellenberg,et al.  A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.

[10]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Trojanowski,et al.  The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”) , 1998, Journal of neuropathology and experimental neurology.

[12]  B. Ghetti,et al.  Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies , 1998, Brain pathology.

[13]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[14]  M D'Esposito,et al.  Recovery of memory and executive function following anterior communicating artery aneurysm rupture , 1996, Journal of the International Neuropsychological Society.

[15]  C. Elfgren,et al.  Performance on Neuropsychological Tests Related to Single Photon Emission Computerised Tomography Findings in Frontotemporal Dementia , 1996, British Journal of Psychiatry.

[16]  N Butters,et al.  Detection of dementia of the Alzheimer type in a population-based sample: Neuropsychological test performance , 1995, Journal of the International Neuropsychological Society.

[17]  Y. Agid,et al.  Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[18]  B. Snow,et al.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.

[19]  J. Grafman,et al.  Frontal lobe function in progressive supranuclear palsy. , 1990, Archives of neurology.

[20]  E. Miller,et al.  Verbal fluency as a function of a measure of verbal intelligence and in relation to different types of cerebral pathology. , 1984, The British journal of clinical psychology.

[21]  G. Schellenberg,et al.  Correction: A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) (Brain (1999) 122, 4 (741-756)) , 1999 .